Back to search
FDAFDA · Food and drugs·Recall number D-0913-2018

Enalapril Maleate Tablets USP; 2.5 mg NDC code 64679-923-03. 1000 Tablets HDPE container pack with Non CRC cap and 2 desiccants further packed in E-flute cartons.

Published July 18, 2018 · Recall initiated: June 19, 2018

Summary

FDA records drug Class III recall D-0913-2018, published July 18, 2018 and initiated June 19, 2018. Recalling firm: Wockhardt Limited; Status: Terminated; Reported quantity: 17,628 tablets; Lot: Batch# DR10447 (Exp: 4/19); Batch# DR10996 (Exp: 10/19); Batch# DS10201 (Exp: 2/20); and Batch# DR10319 (Exp: 3/20). Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Wockhardt Limited
Distributor
Nationwide.
Lot
Batch# DR10447 (Exp: 4/19); Batch# DR10996 (Exp: 10/19); Batch# DS10201 (Exp: 2/20); and Batch# DR10319 (Exp: 3/20).
Risk classification
Class III
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Enalapril Maleate Tablets USP; 2.5 mg NDC code 64679-923-03. 1000 Tablets HDPE container pack with Non CRC cap and 2 desiccants further packed in E-flute cartons. recalled?

Yes. FDA published recall D-0913-2018 on July 18, 2018. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Stop using or selling the product and check the official FDA notice (D-0913-2018) for return or repair instructions.